Skip to main content

Table 1 Clinical and pathological characteristics of patients with FGFR3 mutation detected in cystectomy

From: Circular RNA hsa_circ_0068871 regulates FGFR3 expression and activates STAT3 by targeting miR-181a-5p to promote bladder cancer progression

Patient

Age

Gender

Pathological stage

FGFR3 mutation

FGFR3 expression

Tumor size (cm)

T1

57

Male

T1N1M1

–

High

10

T2

51

Male

T3aN2M0

–

Low

2.5

T3

91

Male

T2aN0M0

–

Low

1.3

T4

70

Male

T1N0M1

c.1138G > A

High

1.1

T5

80

Male

T2bN0M0

–

Low

4.9

T6

73

Male

T4N2M1

–

High

4.0

T7

73

Male

T3bN0M0

–

High

7.5

T8

70

Male

T3aN0M0

–

High

4.0

T9

42

Female

T3bN1M1

–

High

4.8

T10

66

Female

T2aN0M0

–

Low

1.5

T11

48

Male

T2aN0M0

–

High

1.0

T12

54

Male

T3aN1M0

–

High

2.5